Trial Profile
An Efficacy Study of Single-Dose Levalbuterol Tartrate HFA MDI Versus Placebo in Prevention of EIB in Subjects 18 Years of Age and Older With EIB.
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 11 Aug 2023
Price :
$35
*
At a glance
- Drugs Levosalbutamol (Primary)
- Indications Exercise-induced asthma
- Focus Registrational; Therapeutic Use
- Sponsors Sunovion Pharmaceuticals
- 30 Oct 2010 New trial record